Targeted Strategies for Today's Evolving Markets

MissionIR Blog

BioTime, Inc. (BTX) to Present at the ROTH Capital Partners 24th Annual Conference

BioTime develops and markets research products in the field of stem cells and regenerative medicine. The company pursues its therapeutic product development strategy through subsidiaries that focus on specific organ systems and related diseases for which there is a high unmet medical need. BioTime’s lead product, Hextend®, is a blood plasma volume expander manufactured and distributed in the U.S. For more information visit the company’s Web site at www.biotimeinc.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *